# Diagnostics and Early Detection

**Funder:** Cancerfonden
**Budget:** Up to SEK 10M/year for 3–5 years, max SEK 30M per grant
**Duration:** 3–5 years
**Consortium:** No
**Application:** Single stage; requires Head of Department (and clinical head if applicable) digital signature via BankID before applicant submits
**TRL:** 4+
**Eligible countries:** SE
**Official call:** https://www.cancerfonden.se/forskning/for-forskare/sok-anslag-for-forskare/guidelines-early-detection
**Last verified:** 5 July 2026

## Eligibility & scope

Open to experienced PIs (PhD awarded by 31 Dec 2021) employed ≥20% at a Swedish university or healthcare institution. Covers two categories: (A) developing new early cancer detection methods (biosamples, imaging, AI/data); (B) validating methods with existing proof-of-concept (TRL ≥4). Excludes prognostic/predictive biomarkers and detection of metastatic/recurrent disease. Application and research programme must be in English; popular science summary in Swedish.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/cancerfonden-diagnostics-and-early-detection-2026) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.